Month: August 2021

STAMFORD, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) today announced that its financial results for the second quarter of fiscal 2022 will be released before market open on Thursday, September 9, 2021. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-6780) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.lovesac.com. A recorded replay of the conference call will be available within two hours of the conclusion of the call and can be accessed online at investor.lovesac.com for 90 days. In addition, the Company announced its...

Fiscal 2021 Annual Revenue of $6.6M Representing an Increase of 270% Year-Over-Year Filter Product Revenue Increased 68% Sequentially, and Over 440% Year-Over-Year Robust Customer Activity and Design Win Pipeline in 5G Mobile, WiFi CPE, Infrastructure and Other Markets XBAW Filters Entering Production in Core WiFi 6E and Network Infrastructure Segments in 2H CY2021 Company to Host Investor Update Call Today at 8:00 am EDTCharlotte, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today a 270% year-over-year increase in revenue to $6.6 million for the 2021 fiscal year ended June 30, 2021. Q4 fiscal 2021 revenue was...

CHESTERBROOK, Penn., Aug. 30, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the acceptance of two abstracts at ANESTHESIOLOGY® 2021. Both abstracts highlight safety data from the OLINVYK (oliceridine) injection program. The meeting is sponsored by the American Society of Anesthesiologists and will be held on October 8th to 12th in San Diego, California. “I am pleased to have the opportunity to present additional compelling data from the OLINVYK development program,” said Mark A. Demitrack, M.D., Senior Vice President and Chief Medical Officer of Trevena. “The selection of one of our posters as a top research abstract is encouraging and speaks to the continued...

Integrated Rehab and Performance Re-Branded as IRP Health to Better Reflect its Planned Evolution into a Multidisciplinary Business VANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that its wholly-owned subsidiary, Integrated Rehab and Performance Ltd., is expanding its business through the addition of four new, veteran-focused, multidisciplinary clinics in the Comox Valley, Ottawa, Halifax and Surrey (the “New Clinics”). The Comox Valley location is scheduled to begin offering programs on September 6, 2021 and the Ottawa location is also expected to be opened in the month...

NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T-cell therapies utilizing its DeltEx platform, today announced that William Ho, President, Chief Executive Officer and co-founder of IN8bio, will present at the NewYorkBIO Virtual Breakfast Series and the virtual H.C. Wainwright 23rd Annual Global Investment Conference.Event: NewYorkBIO Virtual Breakfast SeriesDate: August 31Presentation: Webinar – Fireside ChatTime: August 31st at 9 am EDTLink: https://bit.ly/3DkM2Rn   Event: H.C. Wainwright 23rd Annual Global Investment ConferenceDate: September 13-14thPresentation: Video presentationTime: Available starting September 13th at 7 am EDTLink: https://bit.ly/3jlRaMQWebcasts...

Drill Hole LocationsProposed Drill hole location over CSAMT level showing resistivity (high=white / low=purple)Trucking Distance From Proposed Grassy Mountain OperationWATCH VIDEO SUMMARY OF THE PRESS RELEASE WINNEMUCCA, Nev., Aug. 30, 2021 (GLOBE NEWSWIRE) — Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or “the Company”) announced today that it has initiated a drill program at the Frost project located 12 miles southwest of the Company’s high-grade Grassy Mountain gold project in Eastern Oregon. As previously announced, Paramount received all required permits from State and Federal authorities to drill its Frost property in April 2021. Paramount President & COO Glen van Treek noted that the Frost property is a very close analog to the Grassy Mountain high grade deposit now in the...

Else Plant-Based Complete Nutrition Product Selected by Scientists, editors and parents who evaluated hundreds of baby and child products over months, to pick top-tested game-changersGood HousekeepingGood Housekeeping Parenting AwardsVANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, announces that it has received Good Housekeeping’s Parenting Award for 2021 for its Plant-Based Completed Nutrition for Toddlers product. Else Toddler Nutrition was selected in the fan favorite category for Balanced Baby Nutrition. The selection is conducted by a panel of scientists, editors, and parents, evaluating hundreds of products impacting U.S. families...

LOS ANGELES, Aug. 30, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced the appointment of internationally renowned scientists and public health leaders to a Scientific Advisory Board (SAB) focused on potential inhaled treatment and prevention of any current or future variants of SARS-CoV-2 – the virus that causes COVID-19 – and Influenza.Dr. Peter Piot, KCMG, FRCP, FMedSci, Chairperson of the SAB, is the Handa Professor of Global Health, London School of Hygiene and Tropical Medicine, former founding Director of UNAIDS and co-discoverer of the Ebola virus. He is also a member of the US National Academy of Medicine.Dr. Richard Whitley, MD, Distinguished Professor, University of Alabama Birmingham, is a...

Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic NEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) — Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr. Levangie is also appointed as a member of the Company’s remuneration committee.   Mr. Levangie is an experienced executive and long-serving board director in the diagnostics and medical devices industry. He is co-founder and manager of ATON Partners, a private investment firm, and president and CEO of CereVasc, LLC, a medical device company. He also has served on the board of directors of Exact Sciences Corporation (NASDAQ: EXAS) since 2010. From 2013 through January 2017, Mr. Levangie served as...